"Most of the uncertainties in the sector have been resolved. There is human capital to make mining possible, and stable institutions and transparency to give foreign investors peace of mind."
"We are always seeking near-term production increases through better efficiencies and productivity, but making a significant impact by 2027 will be tough for us and the industry."
"While being local offers the advantage of swiftly managing stock shortages, the real key is staying close to the client and providing top-tier support."
"We have developed an ambitious five-year business plan for Chile, identifying a potential market of over US$2 billion in services and potential tenders where we can participate."
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.